Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Health surveillance data

Currently viewing:

Administrative data

Endpoint:
health surveillance data
Type of information:
migrated information: read-across based on grouping of substances (category approach)
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Read-across: exposure to various chromium species. Acceptable. Well-documented report.

Data source

Reference
Reference Type:
publication
Title:
A survey of respiratory symptoms and lung function in ferrochromium and ferrosilicon workers.
Author:
Langård, S.
Year:
1980
Bibliographic source:
Int Arch Occup Environ Health.46(1): 1-9.

Materials and methods

Study type:
medical screening
Endpoint addressed:
repeated dose toxicity: inhalation
Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
A questionnaire was used to record respiratory symptoms, smoking habits, detailed occupational history, and a past history of chest diseases among 60 ferrochromium plant workers. A medical examination of chest, heart and upper airways was carried out for all participants. Forced vital capacity and forced expiratory volume one second (FEV1) were recorded three times in each worker, abnd chest X-rays were taken to exclude pneumocosis or other parenchymal fibrotic process in the lungs. Expectorate samples were also obrained on three successive days.
GLP compliance:
no

Test material

Constituent 1
Reference substance name:
various Cr-compounds
IUPAC Name:
various Cr-compounds
Details on test material:
At the ferrochromium furnaces, the airborne chromium concentration was 0.02-0.19 mg/m3. 11-33% of the airborne chromium was water soluble, and was mainly supposed to consist of chromium (VI) compounds.

Method

Type of population:
occupational
Ethical approval:
not specified
Details on study design:
60 ferrochromium workers who had mainly worked at the ferrochromium furnaces or close to these were selected for the study. A questionnaire was used to record respiratory symptoms, smoking habits, detailed occupational history, and a past history of chest diseases among the workers. A medical examination of chest, heart and upper airways was carried out for all participants. Forced vital capacity and forced expiratory volume one second (FEV1) were recorded three times in each worker, and chest X-rays were taken to exclude pneumocosis or other parenchymal fibrotic process in the lungs. Expectorate samples were also obrained on three successive days. The prevalence of respiratory symptoms presented in two other Norwegian studies was used as reference.

Results and discussion

Results:
Among the 60 workers, two cases of perforated nasal septum were observed, and 25% suffered from bronchitis symptoms. However, the author concluded that the nasal perforations were indicative of previous exposure to hexavalent chromium. No connection between the presence of chromates and generalized obstructive lung diseases could be documented.

Applicant's summary and conclusion

Conclusions:
There was no connection between the presence of chromates and generalized obstructive lung diseases among ferrochromium workers. Two cases of perforated nasal septum were observed, but due to the mixed dust exposure (including hexavalent chromium), no conclusions can be made on the specific effects of ferrochromium.
Executive summary:

The study monitored the health status (including respiratory symptoms, smoking habits, detailed occupational history, and a past history of chest diseases) of 60 ferrochromium plant workers. A medical examination of chest, heart and upper airways was carried out for all participants. Forced vital capacity and forced expiratory volume one second (FEV1) were recorded three times in each worker, and chest X-rays were taken to exclude pneumocosis or other parenchymal fibrotic process in the lungs. Expectorate samples were also obrained on three successive days.

The analysis of the connection between health status and occupational exposure revealed that there was no connection between the presence of chromates and generalized obstructive lung diseases among ferrochromium workers. Two cases of perforated nasal septum were observed, but due to the mixed dust exposure (including hexavalent chromium), no conclusions can be made on the specific effects of ferrochromium.